ask="71.20"
ask_size="100"
average_daily_volume="1052870"
bid="50.15"
bid_size="600"
book_value="10.71"
change="-0.78"
change_from_200_day_moving_average="0.59"
change_from_50_day_moving_average="7.62"
change_from_52_week_high="-29.59"
change_From_52_week_low="19.14"
change_in_percent="-1.52%"
close="50.52"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.09"
eps_estimate_next_quarter="-1.30"
eps_estimate_next_year="-4.74"
ex_dividend_date="N/A"
float_shares="71075000"
high="52.97"
high_52_weeks="80.11"
last_trade_date="3/2/2017"
last_trade_price="50.52"
last_trade_size="33471"
last_trade_time="4:00pm"
low="50.01"
low_52_weeks="31.38"
market_capitalization="4.35B"
moving_average_200_day="49.93"
moving_average_50_day="42.90"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="62.73"
open="51.00"
pe_ratio="N/A"
peg_ratio="-0.22"
percent_change_from_200_day_moving_average="+1.19%"
percent_change_from_50_day_moving_average="+17.77%"
percent_change_from_52_week_high="-36.94%"
percent_change_from_52_week_low="+60.99%"
previous_close="51.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.79"
price_per_sales="93.57"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="10.08"
stock_exchange="NMS"
symbol="ALNY"
volume="997525"
weeks_range_52="31.38 - 80.11"
